Retinol vs retinal: what the research actually shows

The short answer: retinal is one step closer, not proven stronger

Retinol and retinal are both vitamin A derivatives that your skin can convert into retinoic acid, the active form of the prescription ingredient tretinoin. Retinol needs two conversions to get there, while retinal needs only one.

Our bottom line: retinal is the shorter path, and the small trial data look encouraging. What we did not find is a trial that puts retinal against retinol at the same concentration, so claims that it is simply stronger are unproven.

How the conversion works

Retinyl esters are broken down into retinol, retinol is oxidized to retinaldehyde, and retinaldehyde is oxidized again to retinoic acid. Retinal sits in the middle, so one fewer step is needed before the acid forms.

That is the logic behind the faster claim, and it is biologically plausible. A shorter pathway alone, however, does not tell you how much better a product performs on skin.

What the clinical trials show for retinal

Most retinal-specific data are older and small. An open trial in 32 women used 0.05% retinaldehyde for four months and reported less surface roughness and coarse wrinkling in an overview of retinoid skin-aging trials.

A randomized, vehicle-controlled trial with 125 participants compared 0.05% retinal with 0.05% retinoic acid. Both were equally effective for wrinkles and roughness, and the retinal group showed increased epidermal thickness and elasticity compared with control, as reported in a focused review of antiaging retinoids.

A review of the clinical literature calls retinal's antiaging evidence stronger than the evidence for retinyl esters. It also describes a 12-week split-face trial with 30 people in which a retinal nanoformulation outperformed 0.025% tretinoin on several measures, though that is a single small study. The 0.05% retinal cream did not differ significantly from tretinoin, but tretinoin caused more local irritation and lower compliance, per a retinaldehyde serum study.

Retinol vs retinal: the comparison that is missing

The one retinol comparison we found is a 2024 randomized trial of 48 people, but it tested oleyl adapalenate, an adapalene precursor, against 0.5% retinol over 12 weeks. Wrinkle severity improved 9.45% with the precursor versus 4.11% with retinol, and the precursor was better tolerated, according to a head-to-head adapalene precursor trial.

Potency, penetration and irritation

You will often see the claim that retinal is about 10 times more bioavailable than retinol. We found that figure repeated as background in a 2024 serum study, which did not measure it, and we could not verify the original source. Treat the 10x number as unproven.

In an in vivo penetration study, the dose-response stopped rising above about 0.25% retinol or 0.5% retinal, so higher strengths added little in that model. Retinol also penetrated unoccluded skin better than retinyl palmitate or retinoic acid, per a penetration study of unoccluded skin.

On irritation, a 14-day repeated insult patch test with 6 people and a 44-week study with 355 people compared the three retinoids. We could retrieve the designs but not the outcomes, so we cannot tell you how they compared, as described in a tolerance profile study.

In vitro, retinal was the only one of three retinoids to show antibacterial activity against gram-positive reference strains, per an antibacterial retinoid study. The clinical relevance is unclear.

What to do with this

If you are choosing between them, the honest answer is that the evidence does not crown either one. Retinol is the more familiar and widely sold option. Retinal may act faster, but the trials are small and the head-to-head data are missing.

For how to start retinol and what irritation looks like, see our retinol guide. We also did not retrieve guidance from the AAD, FDA, NIH or ACOG on either ingredient, including pregnancy, so check those sources before you buy, especially if you are pregnant or planning to be.